+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Growth Hormone Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Product, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 129 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 4452009
Description Jump to:
The global human growth hormone market size is expected to reach USD 14.28 billion by 2030, growing at a CAGR of 12.3% from 2023 to 2030. The market is witnessing growth due to an increase in the incidence of growth hormone deficiency and other growth-related disorders. In addition, market growth is being driven by intense competition among key players striving to develop innovative and cost-effective treatment options. The increasing parental concerns regarding the growth of their children are contributing to the rising demand for human growth hormone (HGH) therapy. Reports from Canada Today highlight that parents are showing particular concern about the height of their children and are willing to invest in treatment options for dwarfism.

Similarly, in China, there is a high demand for HGH treatment for children, even in the absence of any medical abnormality. These growing concerns about the normal development of children have opened up new opportunities for industry players. North America is projected to experience rapid growth driven by increasing healthcare awareness among the population, significant government initiatives, and favorable reimbursement policies in the region. Furthermore, a rise in research & development activities, the availability of sufficient research funding, and the presence of organizations that actively promote awareness & treatment options are expected to drive the regional market growth.

In addition, the North America market benefits from the strong presence of top industry players, including Pfizer Inc. and Lilly, which significantly contributes to its profitable revenue share in the global industry. The increasing number of regulatory approvals and the introduction of innovative HGH treatment regimens are also contributing to the market expansion. For instance, in January 2022, Pfizer, Inc. and OPKO Health, Inc. obtained approval from the U.S. Food and Drug Administration (FDA) for NGENLA's commercialization, an advanced long-acting growth hormone injection with a once-a-week dosage for treating growth hormone deficiency in the country. NGENLA is anticipated to be available for prescription in the United States starting from August 2023.

Similarly, in August 2021, the U.S. FDA approved lonapegsomatropin-tcgd (SKYTROFA) introduced by Ascendis Pharma, for the treatment of development stoppage in pediatric patients. These regulatory approvals and the launch of novel HGH regimens are contributing to the market's expansion and driving further advancements in the field. North America held the largest revenue share in 2022 due to a rise in awareness among people about growth hormone deficiency and its treatments, along with an emphasis on early diagnosis. Asia Pacific is expected to exhibit the fastest CAGR over the forecast period due to the rising investments by leading players and the surge in generic adoption in the region.

India and China are anticipated to offer significant opportunities for the advancement of the healthcare sector, driven by their large population. Consequently, pharmaceutical companies, including those specializing in HGH drugs, are making substantial investments in these countries. Pfizer Inc., Novartis AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd. dominate the global market. These companies adopt strategies, such as new product development, merger & acquisition, and partnership, to increase their market share. In June 2023, the global health and fitness industry leader, Domestic Supply, launched a scientifically validated HGH supplement. This novel product marks a remarkable advancement in the field of performance enhancement and overall well-being, offering health-conscious individuals worldwide an enhanced quality of life

Human Growth Hormone Market Report Highlights

  • Based on product, the others segment including the short-acting growth hormone dominated the market in 2022. Increased approvals by regulatory authorities for short-acting GH therapies, along with ongoing R&D activities in this field, contribute to the growth of the market
  • The growth hormone deficiency application segment dominated the market in 2022 due to the high awareness levels about the treatment of growth hormone deficiency and early diagnosis in humans, coupled with the introduction of new drugs in the global market
  • Based on the end-use, the hospital pharmacy segment dominated the market in 2022 due to the increased number of hospital visits driven by rising awareness about growth hormone deficiency and the effectiveness of its treatments
  • Recombinant DNA technology plays a crucial role in designing and manufacturing numerous drugs, particularly those used for growth hormone replacement treatment in both adults and children who suffer from growth hormone deficiency
  • The market is expected to witness increased revenue generation in the at-home A1C testing segment, positioning it as the second-largest testing segment in 2022, primarily driven by higher adoption rates


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Application segment
1.1.1.2. Product segment
1.1.1.3. Distribution channel segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Application and Product Snapshot
2.3. Distribution Channel Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of human growth hormone
3.2.1.2. Growing investments and governmental funding in the development of diagnostics
3.2.1.3. Growing awareness of human growth hormone
3.2.2. Market Restraint Analysis
3.2.2.1. Shift of funds to tackle other diseases in low health budgets.
3.2.2.2. Shortage of funding from international partners and foreign government
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Human Growth Hormone Market: Product Movement Analysis
4.2. Long Acting
4.2.1. Long Acting Market, 2018 - 2030 (USD Million)
4.3. Others
4.3.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Human Growth Hormone Market: Application Movement Analysis
5.2. Growth Hormone Deficiency
5.2.1. Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
5.2.2. Adult Growth Hormone Deficiency
5.2.2.1. Adult Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
5.2.3. Pediatric Growth Hormone Deficiency
5.2.3.1. Pediatric Growth Hormone Deficiency Market, 2018 - 2030 (USD Million)
5.3. Turner Syndrome
5.3.1. Turner Syndrome Market, 2018 - 2030 (USD Million)
5.4. Idiopathic Short Stature
5.4.1. Idiopathic Short Stature Market, 2018 - 2030 (USD Million)
5.5. Prader-Willi Syndrome
5.5.1. Prader-Willi Syndrome Market, 2018 - 2030 (USD Million)
5.6. Small for Gestational Age
5.6.1. Small for Gestational Age Market, 2018 - 2030 (USD Million)
5.7. Other
5.7.1. Other Market, 2018 - 2030 (USD Million)
Chapter 6. Distribution Channel Business Analysis
6.1. Human Growth Hormone Market: Distribution Channel Movement Analysis
6.2. Hospital Pharmacy
6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
6.3. Retail Pharmacy
6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
6.4. Online Pharmacy
6.4.1. Online Pharmacy Market, 2018 - 2030 (USD Million)
6.5. Specialty Pharmacy
6.5.1. Specialty Pharmacy Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Human Growth Hormone Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. U.S. Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Competitive Scenario
7.2.4.3. Regulatory Framework
7.2.4.4. Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. France Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.10. Denmark
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.3.11. Russia
7.3.11.1. Key Country Dynamics
7.3.11.2. Competitive Scenario
7.3.11.3. Regulatory Framework
7.3.11.4. Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. China Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. India Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.4.9. Singapore
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Novo Nordisk A/S
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Pfizer, Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Eli Lilly and Company
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Sandoz International GmbH (Novartis AG)
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Merck KGaA
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Genentech, Inc (Roche)
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Ferring Pharmaceuticals
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Teva Pharmaceutical Industries, Ltd
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Ipsen
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Human Growth Hormone Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 5 Global Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 6 Global Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 7 North America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 9 North America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 11 U.S. Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 12 U.S. Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 Canada Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 15 Canada Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 16 Canada Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Europe Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
Table 18 Europe Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 19 Europe Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 20 Europe Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 21 UK Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 22 UK Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 23 UK Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Germany Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 25 Germany Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 26 Germany Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 France Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 28 France Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 29 France Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 30 Italy Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 31 Italy Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 32 Italy Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Spain Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 34 Spain Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 35 Spain Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Russia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 37 Russia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 38 Russia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Denmark Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 40 Denmark Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 41 Denmark Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Sweden Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 43 Sweden Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 44 Sweden Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 45 Norway Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 46 Norway Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 47 Norway Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 China Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 53 China Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 54 China Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 India Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 56 India Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 57 India Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 58 South Korea Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 59 South Korea Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 60 South Korea Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 61 Japan Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 62 Japan Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 63 Japan Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Singapore Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 65 Singapore Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 66 Singapore Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 Australia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 68 Australia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 69 Australia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 70 Thailand Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 71 Thailand Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 72 Thailand Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Latin America Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
Table 74 Latin America Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 75 Latin America Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 76 Latin America Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 77 Brazil Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 78 Brazil Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 79 Brazil Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Mexico Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 81 Mexico Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 82 Mexico Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 Argentina Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 84 Argentina Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 85 Argentina Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Human Growth Hormone Market, By Country, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 88 Middle East & Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 89 Middle East & Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 90 South Africa Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 91 South Africa Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 92 South Africa Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 Saudi Arabia Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 94 Saudi Arabia Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 95 Saudi Arabia Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 96 UAE Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 97 UAE Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 98 UAE Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 99 Kuwait Human Growth Hormone Market, By Product, 2018 - 2030 (USD Million)
Table 100 Kuwait Human Growth Hormone Market, By Application, 2018 - 2030 (USD Million)
Table 101 Kuwait Human Growth Hormone Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Human Growth Hormone Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Human growth hormone market: Product outlook and key takeaways
Fig. 15 Human growth hormone market: Product movement analysis & market share 2022 & 2030
Fig. 16 Long-acting market, 2018 - 2030 (USD Million)
Fig. 17 Others market, 2018 - 2030 (USD Million)
Fig. 18 Human growth hormone market: Application outlook and key takeaways
Fig. 19 Human growth hormone market: Application movement analysis & market share 2022 & 2030
Fig. 20 Growth hormone deficiency market, 2018 - 2030 (USD Million)
Fig. 21 Adult growth hormone deficiency market, 2018 - 2030 (USD Million)
Fig. 22 Pediatric growth hormone deficiency market, 2018 - 2030 (USD Million)
Fig. 23 Turner syndrome market, 2018 - 2030 (USD Million)
Fig. 24 Idiopathic short stature market, 2018 - 2030 (USD Million)
Fig. 25 Prader-Willi syndrome market, 2018 - 2030 (USD Million)
Fig. 26 Small for gestational age market, 2018 - 2030 (USD Million)
Fig. 27 Other market, 2018 - 2030 (USD Million)
Fig. 28 Human growth hormone market: Distribution channel method outlook and key takeaways
Fig. 29 Human growth hormone market: Distribution channel method movement analysis & market share 2022 & 2030
Fig. 30 Hospital pharmacy market, 2018 - 2030 (USD Million)
Fig. 31 Retail pharmacy market, 2018 - 2030 (USD Million)
Fig. 32 Online pharmacy market, 2018 - 2030 (USD Million)
Fig. 33 Specialty pharmacy market, 2018 - 2030 (USD Million)
Fig. 34 Regional Marketplace: Key Takeaways
Fig. 35 Regional Outlook, 2022 & 2030
Fig. 36 Regional Market Dashboard
Fig. 37 Regional Market Place: Key Takeaways
Fig. 38 North America
Fig. 39 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 40 U.S. Key Country Dynamics
Fig. 41 U.S. America Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 42 Canada Key Country Dynamics
Fig. 43 Canada Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 44 Europe Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 45 UK Key Country Dynamics
Fig. 46 UK Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 47 Germany Key Country Dynamics
Fig. 48 Germany Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 49 France Key Country Dynamics
Fig. 50 France Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 51 Italy Key Country Dynamics
Fig. 52 Italy Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 53 Spain Key Country Dynamics
Fig. 54 Spain Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 55 Sweden Key Country Dynamics
Fig. 56 Sweden Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 57 Norway Key Country Dynamics
Fig. 58 Norway Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 59 Denmark Key Country Dynamics
Fig. 60 Denmark Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 61 Russia Key Country Dynamics
Fig. 62 Russia Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 63 Turkey Key Country Dynamics
Fig. 64 Turkey Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific America Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 66 Japan Key Country Dynamics
Fig. 67 Japan Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 68 China Key Country Dynamics
Fig. 69 China Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 70 India Key Country Dynamics
Fig. 71 India Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 72 Australia Key Country Dynamics
Fig. 73 Australia Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 74 Thailand Key Country Dynamics
Fig. 75 Thailand Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 76 South Korea Key Country Dynamics
Fig. 77 South Korea Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 78 Indonesia Key Country Dynamics
Fig. 79 Indonesia Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 80 Latin America Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 81 Brazil Key Country Dynamics
Fig. 82 Brazil Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 83 Mexico Key Country Dynamics
Fig. 84 Mexico Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 85 Argentina Key Country Dynamics
Fig. 86 Argentina Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 87 Middle East and Africa America Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 88 South Africa Key Country Dynamics
Fig. 89 South Africa Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 90 Saudi Arabia Key Country Dynamics
Fig. 91 Saudi Arabia Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 92 UAE Key Country Dynamics
Fig. 93 UAE Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 94 Kuwait Key Country Dynamics
Fig. 95 Kuwait Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 96 Nigeria Key Country Dynamics
Fig. 97 Nigeria Human Growth Hormone Market, 2018 - 2030 (USD Million)
Fig. 98 Strategy Mapping

Companies Mentioned

  • Novo Nordisk A/S
  • Pfizer, Inc
  • Eli Lilly and Company
  • Sandoz International GmbH (Novartis AG)
  • Merck KGaA
  • Genentech, Inc (Roche)
  • Ferring Pharmaceuticals
  • Teva Pharmaceutical Industries, Ltd
  • Ipsen

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages129
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 5.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.28 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Human Growth Hormone Market by Route of Administration (Intramuscular, Intravenous, Oral), Type (Amino Acid Derivatives, Peptide Hormones, Steroid Hormones), Distribution, Application - Forecast 2024-2030 - Product Image

Global Human Growth Hormone Market by Route of Administration (Intramuscular, Intravenous, Oral), Type (Amino Acid Derivatives, Peptide Hormones, Steroid Hormones), Distribution, Application - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Synthetic Hormones Market by Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), Route of Administration (Intravenous, Nasal, Oral), Application, End-User - Forecast 2024-2030 - Product Image

Global Synthetic Hormones Market by Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), Route of Administration (Intravenous, Nasal, Oral), Application, End-User - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Recombinant Hormone Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Image

Recombinant Hormone Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • 115 Pages
  • Global
From
Human Growth Hormone Drugs - Global Strategic Business Report - Product Image

Human Growth Hormone Drugs - Global Strategic Business Report

  • Report
  • 335 Pages
  • Global
From
Global Human Growth Hormone Market Report and Forecast 2023-2031 - Product Image

Global Human Growth Hormone Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.